Related Experiment Video
Updated: Aug 22, 2025

07:27
Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
10.3K
Addressing depressive disorders among people with HIV
Andres Fuenmayor1, Francine Cournos1
1Columbia University, New York, New York, USA.
Topics in Antiviral Medicine
|November 8, 2022
Summary
Depressive disorders are common in people with HIV, worsening health outcomes. This guide helps HIV primary care clinicians detect, diagnose, and manage depression, even with limited behavioral health support.
Area of Science:
- Psychiatry
- Infectious Diseases
- Primary Care Medicine
Background:
- Depressive disorders are the most prevalent psychiatric conditions in individuals living with HIV.
- Untreated depression in people with HIV is linked to adverse outcomes, including poor medication adherence, increased illness, and higher mortality rates.
- The integration of behavioral health services into HIV primary care is often limited in the United States.
Purpose of the Study:
- To provide guidance on the detection, differential diagnosis, and management of depressive disorders in adults within US HIV primary care settings.
- To equip non-specialist clinicians in HIV care with strategies to address depression, particularly in resource-limited environments.
- To support clinicians in managing depressive disorders when access to specialized behavioral health services is scarce.
Main Methods:
- This article focuses on clinical approaches for diagnosing and managing depression in HIV-positive adults.
- It is designed for primary care providers in HIV settings who may not have extensive behavioral health expertise.
- The content addresses practical strategies for managing depression within the constraints of typical HIV primary care.
Main Results:
- Depression significantly impacts the health and well-being of individuals with HIV.
- Effective management of depression can mitigate negative HIV-related outcomes.
- Primary care settings play a crucial role in addressing mental health needs of people with HIV.
Conclusions:
- Addressing depressive disorders is essential for comprehensive HIV care.
- Primary care clinicians can play a vital role in managing depression among people with HIV, even without integrated behavioral health specialists.
- Improved strategies are needed to support the mental health of this vulnerable population within primary care.
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
198
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
198
Depression: Overview
320
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
320
Depressive Disorders: Etiology
152
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
152
Antidepressant Drugs: MAOIs and Other Agents
306
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
306
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K
Antidepressant Drugs: Overview
687
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
687

